Entrez ID	Gene Symbol	Gene Name	Refseq mRNA	Refseq Protein	Ensembl Gene ID	UCSC Genomic Coordinates	GO Categories	Sources
207	AKT1	v-akt murine thymoma viral oncogene homolog 1	NM_001014431	NP_005154.2	ENSG00000142208	chr14:104307722 - 104330025	anagen;apoptosis;apoptotic mitochondrial changes;ATP binding;carbohydrate metabolic process;cytoplasm;G-protein coupled receptor protein signaling pathway;germ cell development;glucose metabolic process;glucose transport;glycogen biosynthetic process;identical protein binding;inflammatory response;insulin receptor signaling pathway;insulin-like growth factor receptor signaling pathway;lamellipodium;nitric oxide biosynthetic process;nucleotide binding;nucleus;peptidyl-serine phosphorylation;protein amino aci	Alpha6Beta4 Integrin,  Androgen Receptor,  EGFR1,  Kit Receptor,  TNF_alpha_NF_kB,  Wnt,  Hahn and Weinberg 2002,  Protein Kinase,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene
324	APC	adenomatosis polyposis coli	NM_001127511, NM_001127510	NP_001120983.1, NP_001120982.1	ENSG00000134982	chr5:112118486 - 112207722	anterior/posterior pattern formation;axis specification;beta-catenin binding;beta-catenin destruction complex;cell adhesion;cell cycle;cell cycle arrest;centrosome;cytoplasm;dorsal/ventral pattern formation;kinetochore;lateral plasma membrane;microtubule binding;negative regulation of cell proliferation;negative regulation of cyclin-dependent protein kinase activity;negative regulation of microtubule depolymerization;nucleus;protein complex assembly;protein kinase binding;protein kinase CK2 regulator activi	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
581	BAX	BCL2-associated X protein	NM_138763, NM_004324, NM_138764, NM_138761, NM_138765	NP_620118.1, NP_004315.1, NP_620119.1, NP_620116.1, NP_620120.1	ENSG00000087088	chr19:54149997 - 54156166	apoptosis;apoptotic mitochondrial changes;B cell apoptosis;B cell homeostatic proliferation;BH3 domain binding;caspase activation;caspase activation via cytochrome c;cell cycle;cellular_component;cleavage of lamin;cytoplasm;cytosol;cytosolic part;DNA fragmentation during apoptosis;endoplasmic reticulum;endoplasmic reticulum membrane;establishment and/or maintenance of transmembrane electrochemical gradient;germ cell development;induction of apoptosis;induction of apoptosis by extracellular signals;induction	Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Entrez Query:Oncogene
673	BRAF	v-raf murine sarcoma viral oncogene homolog B1	NM_004333	NP_004324.2	ENSG00000157764	chr7:140080865 - 140270972	anti-apoptosis;ATP binding;cytoplasm;diacylglycerol binding;intracellular signaling cascade;metal ion binding;nucleotide binding;organ morphogenesis;plasma membrane;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;receptor signaling protein activity;transferase activity;zinc ion binding	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tyrosine Kinase,  Entrez Query:Oncogene,  Missense mutation
672	BRCA1	breast cancer 1, early onset	NM_007298, NM_007300, NM_007303, NM_007299, NM_007294, NM_007302, NM_007304, NM_007305	NP_009229.1, NP_009231.1, NP_009234.1, NP_009230.1, NP_009227.1, NP_009228.1, NP_009235.2, NP_009236.1	ENSG00000012048	chr17:38451220 - 38529639	androgen receptor binding;androgen receptor signaling pathway;BRCA1-BARD1 complex;cell cycle;cell cycle checkpoint;cellular_component;chromosome segregation;DNA binding;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;DNA damage response, signal transduction resulting in induction of apoptosis;DNA repair;enzyme binding;fatty acid biosynthetic process;gamma-tubulin ring complex;intracellular;metal ion binding;molecular_function;negative regulatio	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
675	BRCA2	breast cancer 2, early onset	NM_000059	NP_000050.2	ENSG00000139618	chr13:31788597 - 31870907	chromatin remodeling;cytoplasm;DNA repair;double-strand break repair via homologous recombination;establishment and/or maintenance of chromatin architecture;extracellular space;histone acetyltransferase activity;mitotic checkpoint;nucleus;protein binding;regulation of progression through cell cycle;regulation of S phase of mitotic cell cycle;regulation of transcription;secretory granule;single-stranded DNA binding;transcriptional activator activity	Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
595	CCND1	cyclin D1	NM_053056	NP_444284.1	ENSG00000110092	chr11:69165262 - 69175231	cell cycle;cell division;cellular_component;cyclin-dependent protein kinase holoenzyme complex;cyclin-dependent protein kinase regulator activity;cytosol;fat cell differentiation;G1/S transition of mitotic cell cycle;intracellular;nucleus;protein amino acid phosphorylation;protein binding;protein kinase activity;re-entry into mitotic cell cycle;unfolded protein response	Androgen Receptor,  TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Entrez Query:Oncogene,  Translocation
894	CCND2	cyclin D2	NM_001759	NP_001750.1	ENSG00000118971	chr12:4253467 - 4279436	cell cycle;cell division;nucleus;protein binding;regulation of progression through cell cycle	Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Translocation
896	CCND3	cyclin D3	NM_001760	NP_001751.1	ENSG00000112576	chr6:42011655 - 42017365	cell cycle;cell division;nucleus;protein binding;regulation of progression through cell cycle	Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Tumor Suppressor,  Entrez Query:Oncogene,  Translocation
898	CCNE1	cyclin E1	NM_057182	NP_476530.1	ENSG00000105173	chr19:34995302 - 35006524	androgen receptor binding;androgen receptor signaling pathway;cell cycle;cell division;G1/S transition of mitotic cell cycle;nucleus;positive regulation of transcription, DNA-dependent;protein binding;regulation of progression through cell cycle;transcription coactivator activity	Hahn and Weinberg 2002,  Stability
1017	CDK2	cyclin-dependent kinase 2	NM_052827, NM_001798	NP_439892.2, NP_001789.2	ENSG00000123374	chr12:54647059 - 54651676	ATP binding;cell cycle;cell division;cyclin-dependent protein kinase activity;cytoplasm;G2/M transition of mitotic cell cycle;identical protein binding;mitosis;nucleotide binding;nucleus;positive regulation of cell proliferation;protein amino acid phosphorylation;protein serine/threonine kinase activity;regulation of DNA replication;transferase activity;traversing start control point of mitotic cell cycle	ID,  TGFBR,  Hahn and Weinberg 2002,  Protein Kinase,  Stability,  Tumor Suppressor
1019	CDK4	cyclin-dependent kinase 4	NM_000075	NP_000066.1	ENSG00000135446	chr12:56428574 - 56431767	ATP binding;cell cycle;cell division;cell proliferation;cyclin-dependent protein kinase activity;G1/S transition of mitotic cell cycle;nucleotide binding;nucleus;protein amino acid phosphorylation;protein binding;protein kinase activity;regulation of progression through cell cycle;transferase activity	TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Missense mutation
1021	CDK6	cyclin-dependent kinase 6	NM_001259	NP_001250.1	ENSG00000105810	chr7:92082389 - 92300573	ATP binding;cell cycle;cell division;cell proliferation;G1 phase of mitotic cell cycle;nucleotide binding;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;regulation of progression through cell cycle;transferase activity	TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Protein Kinase,  Tumor Suppressor,  Translocation
1026	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)	NM_078467	NP_510867.1	ENSG00000124762	chr6:36759856 - 36761555	cell cycle;cell cycle arrest;cyclin binding;cyclin-dependent protein kinase holoenzyme complex;cyclin-dependent protein kinase inhibitor activity;cytosol;induction of apoptosis by intracellular signals;kinase activity;metal ion binding;negative regulation of apoptosis;negative regulation of cell proliferation;negative regulation of cyclin-dependent protein kinase activity;nucleus;positive regulation of B cell proliferation;positive regulation of non-apoptotic programmed cell death;protein kinase activity;re	TGFBR,  Hahn and Weinberg 2002,  Protein Kinase,  Stability,  Tumor Suppressor
1029	CDKN2A	cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)	NM_000077, NM_058197, NM_058195	NP_000068.1, NP_478104.2, NP_478102.1	ENSG00000147889	chr9:21961001 - 21984453	apoptosis;cell aging;cell cycle;cell cycle arrest;cell cycle checkpoint;cellular_component;cyclin-dependent protein kinase inhibitor activity;cytoplasm;DNA binding;epidermis development;negative regulation of cell proliferation;negative regulation of cyclin-dependent protein kinase activity;nucleolus;nucleoplasm;nucleus;protein binding;regulation of cyclin-dependent protein kinase activity;regulation of transcription, DNA-dependent;rRNA processing;transcription	Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
1977	EIF4E	eukaryotic translation initiation factor 4E	NM_001968	NP_001959.1	ENSG00000151247	chr4:100021201 - 100069286	cytoplasm;eukaryotic translation initiation factor 4F complex;protein binding;regulation of translation;RNA cap binding;translation initiation factor activity;translational initiation	Alpha6Beta4 Integrin,  Hahn and Weinberg 2002,  Stability
2885	GRB2	growth factor receptor-bound protein 2	NM_203506, NM_002086	NP_987102.1, NP_002077.1	ENSG00000177885	chr17:70828043 - 70901304	cell-cell signaling;cytosol;epidermal growth factor receptor binding;epidermal growth factor receptor signaling pathway;insulin receptor signaling pathway;insulin receptor substrate binding;intracellular signaling cascade;Ras protein signal transduction;SH3/SH2 adaptor activity	Alpha6Beta4 Integrin,  EGFR1,  Kit Receptor,  Hahn and Weinberg 2002
3265	HRAS	v-Ha-ras Harvey rat sarcoma viral oncogene homolog	NM_176795, NM_005343	NP_789765.1, NP_005334.1	ENSG00000174775	chr11:522635 - 524322	cell surface receptor linked signal transduction;chemotaxis;cytoplasm;GTP binding;intracellular;membrane;nucleotide binding;organ morphogenesis;plasma membrane;protein C-terminus binding;regulation of progression through cell cycle;small GTPase mediated signal transduction	EGFR1,  Kit Receptor,  Futreal et al 2004,  Hahn and Weinberg 2002,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation
5604	MAP2K1	mitogen-activated protein kinase kinase 1	NM_002755	NP_002746.1	ENSG00000169032	chr15:64466739 - 64570007	ATP binding;cell motility;chemotaxis;keratinocyte differentiation;MAP kinase kinase activity;neuron differentiation;nucleotide binding;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;protein-tyrosine kinase activity;signal transduction;transferase activity	EGFR1,  Hahn and Weinberg 2002
4214	MAP3K1	mitogen-activated protein kinase kinase kinase 1	NM_005921	NP_005912.1	ENSG00000095015	chr5:56147157 - 56225264	apoptotic mitochondrial changes;ATP binding;cellular_component;magnesium ion binding;MAP kinase kinase kinase activity;nucleotide binding;positive regulation of actin filament polymerization;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;regulation of cell migration;transferase activity;transforming growth factor beta receptor signaling pathway;wound healing;zinc ion binding	EGFR1,  TNF_alpha_NF_kB,  Hahn and Weinberg 2002,  Protein Kinase
4193	MDM2	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse)	NM_006881, NM_006878, NM_006882, NM_002392, NM_006879	NP_006872.3, NP_006869.3, NP_006873.3, NP_002383.2, NP_006870.3	ENSG00000135679	chr12:67488524 - 67519896	enzyme binding;intracellular;ligase activity;metal ion binding;negative regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;negative regulator of basal transcription activity;nucleolus;nucleoplasm;nucleus;protein binding;protein complex assembly;protein ubiquitination;regulation of progression through cell cycle;regulation of protein catabolic process;ubiquitin-protein ligase activity;zinc ion binding	Androgen Receptor,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene
4609	MYC	v-myc myelocytomatosis viral oncogene homolog (avian)	NM_002467	NP_002458.2	ENSG00000136997	chr8:128818021 - 128822386	activation of pro-apoptotic gene products;caspase activation;cell cycle arrest;DNA binding;DNA fragmentation during apoptosis;induction of apoptosis by intracellular signals;iron ion homeostasis;negative regulation of survival gene product activity;nucleus;positive regulation of cell proliferation;protein binding;regulation of apoptosis;regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;release of cytochrome c from mitochondria;response to radiation;spindl	EGFR1,  TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Amplification,  Translocation
4763	NF1	neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)	NM_000267, NM_001042492, NM_001128147	NP_000258.1, NP_001035957.1, NP_001121619.1	ENSG00000196712	chr17:26446453 - 26725299	adrenal gland development;biological_process;cell cycle;cellular_component;cytoplasm;enzyme inhibitor activity;GTPase activator activity;heart development;intracellular;molecular_function;negative regulation of cell migration;negative regulation of endothelial cell proliferation;negative regulation of MAPKKK cascade;negative regulation of progression through cell cycle;positive regulation of Ras GTPase activity;protein binding;Ras GTPase activator activity;Ras protein signal transduction;regulation of glial	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4771	NF2	neurofibromin 2 (bilateral acoustic neuroma)	NM_181832, NM_000268, NM_181828, NM_181829, NM_181833, NM_181830	NP_861970.1, NP_000259.1, NP_861966.1, NP_861967.1, NP_861971.1, NP_861969.1	ENSG00000186575	chr22:28329987 - 28420791	cell cycle;cytoplasm;cytoskeletal protein binding;cytoskeleton;negative regulation of cell proliferation;negative regulation of progression through cell cycle;nucleus;plasma membrane;sensory perception of sound;structural molecule activity	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4893	NRAS	neuroblastoma RAS viral (v-ras) oncogene homolog	NM_002524	NP_002515.1	ENSG00000168638	chr1:115052678 - 115060304	GTP binding;GTPase activity;intracellular;membrane;nucleotide binding;regulation of progression through cell cycle;small GTPase mediated signal transduction	EGFR1,  Futreal et al 2004,  Hahn and Weinberg 2002,  Entrez Query:Oncogene,  Missense mutation
5290	PIK3CA	phosphoinositide-3-kinase, catalytic, alpha polypeptide	NM_006218	NP_006209.2	ENSG00000121879	chr3:180399307 - 180434846	1-phosphatidylinositol-3-kinase activity;anti-apoptosis;glucose metabolic process;inositol or phosphatidylinositol kinase activity;insulin receptor substrate binding;lamellipodium;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;phosphoinositide 3-kinase complex;protein amino acid phosphorylation;protein kinase B signaling cascade;regulation of body size;signal transduction;transferase activity	Alpha6Beta4 Integrin,  EGFR1,  Futreal et al 2004,  Hahn and Weinberg 2002,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation
5291	PIK3CB	phosphoinositide-3-kinase, catalytic, beta polypeptide	NM_006219	NP_006210.1	ENSG00000051382	chr3:139856920 - 139960875	1-phosphatidylinositol-3-kinase activity;activation of MAPK activity;calcium ion homeostasis;chemotaxis;embryonic cleavage;G-protein coupled receptor protein signaling pathway;homophilic cell adhesion;inositol or phosphatidylinositol kinase activity;insulin receptor substrate binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;phosphoinositide 3-kinase complex;platelet activation;regulation of cell-matrix adhesion;regulation of progression through cell cycle;signal transduction;transferase activ	Alpha6Beta4 Integrin,  EGFR1,  Hahn and Weinberg 2002
5294	PIK3CG	phosphoinositide-3-kinase, catalytic, gamma polypeptide	NM_002649	NP_002640.2	ENSG00000105851	chr7:106295242 - 106333068	1-phosphatidylinositol-3-kinase activity;G-protein coupled receptor protein signaling pathway;inositol or phosphatidylinositol kinase activity;negative regulation of apoptosis;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;phosphoinositide 3-kinase complex;protein amino acid phosphorylation;protein binding;transferase activity	Alpha6Beta4 Integrin,  EGFR1,  Kit Receptor,  Hahn and Weinberg 2002,  Stability,  Entrez Query:Oncogene
25913	POT1	POT1 protection of telomeres 1 homolog (S. pombe)	NM_015450	NP_001036059.1	ENSG00000128513	chr7:124251251 - 124324463	chromosome;DNA binding;nuclear chromosome, telomeric region;nucleus;protein binding;single-stranded telomeric DNA binding;telomere maintenance;telomere maintenance via telomerase	Hahn and Weinberg 2002
5516	PPP2CB	protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform	NM_004156	NP_004147.1	ENSG00000104695	chr8:30763292 - 30789479	cytoplasm;hydrolase activity;iron ion binding;manganese ion binding;metal ion binding;phosphoprotein phosphatase activity;protein amino acid dephosphorylation;protein binding;protein phosphatase type 2A activity;protein phosphatase type 2A complex	Hahn and Weinberg 2002,  Stability
5728	PTEN	phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	NM_000314	NP_000305.3	ENSG00000171862	chr10:89614206 - 89715209	cell cycle;cell migration;cell proliferation;central nervous system development;cytoplasm;heart development;hydrolase activity;induction of apoptosis;inositol phosphate dephosphorylation;inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity;lipid binding;lipid metabolic process;negative regulation of apoptosis;negative regulation of cell migration;negative regulation of cell proliferation;negative regulation of focal adhesion formation;negative regulation of progression through cell cycle;negative regul	Androgen Receptor,  Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
5894	RAF1	v-raf-1 murine leukemia viral oncogene homolog 1	NM_002880	NP_002871.1	ENSG00000132155	chr3:12601012 - 12635220	apoptosis;ATP binding;cell proliferation;cytoskeleton organization and biogenesis;diacylglycerol binding;intracellular signaling cascade;metal ion binding;mitochondrial outer membrane;nucleotide binding;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;receptor signaling protein activity;transferase activity;zinc ion binding	EGFR1,  Kit Receptor,  Hahn and Weinberg 2002,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene
5925	RB1	retinoblastoma 1 (including osteosarcoma)	NM_000321	NP_000312.2	ENSG00000139687	chr13:47776049 - 47952208	androgen receptor binding;androgen receptor signaling pathway;cell cycle;cell cycle checkpoint;chromatin;chromatin modification;G1 phase;kinase binding;M phase;molecular_function;negative regulation of cell growth;negative regulation of progression through cell cycle;negative regulation of protein kinase activity;negative regulation of transcription from RNA polymerase II promoter;nucleus;PML body;positive regulation of transcription, DNA-dependent;protein binding;regulation of lipid kinase activity;regulat	Androgen Receptor,  ID,  TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
29984	RHOD	ras homolog gene family, member D	NM_014578	NP_055393.1	ENSG00000173156	chr11:66580949 - 66595649	GTP binding;GTPase activity;intracellular;membrane;nucleotide binding;Rho protein signal transduction;small GTPase mediated signal transduction	Hahn and Weinberg 2002
6195	RPS6KA1	ribosomal protein S6 kinase, 90kDa, polypeptide 1	NM_001006665, NM_002953	NP_001006666.1, NP_002944.2	ENSG00000117676	chr1:26744978 - 26773279	ATP binding;magnesium ion binding;nucleotide binding;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;signal transduction;transferase activity	EGFR1,  Kit Receptor,  Hahn and Weinberg 2002,  Protein Kinase,  Stability
6196	RPS6KA2	ribosomal protein S6 kinase, 90kDa, polypeptide 2	NM_001006932, NM_021135	NP_001006933.1, NP_066958.2	ENSG00000071242	chr6:166746239 - 167195648	ATP binding;magnesium ion binding;nucleotide binding;nucleus;protein amino acid phosphorylation;protein kinase cascade;protein serine/threonine kinase activity;transferase activity	EGFR1,  Hahn and Weinberg 2002,  Protein Kinase
6197	RPS6KA3	ribosomal protein S6 kinase, 90kDa, polypeptide 3	NM_004586	NP_004577.1	ENSG00000177189	chrX:20083436 - 20194671	ATP binding;central nervous system development;magnesium ion binding;nucleotide binding;protein amino acid phosphorylation;protein kinase activity;protein serine/threonine kinase activity;signal transduction;skeletal development;transferase activity	EGFR1,  Hahn and Weinberg 2002,  Protein Kinase
7012	TERC	telomerase RNA component			null	chr3:null		Hahn and Weinberg 2002,  Stability
7013	TERF1	telomeric repeat binding factor (NIMA-interacting) 1	NM_003218, NM_017489	NP_003209.2, NP_059523.2	ENSG00000147601	chr8:74083675 - 74120926	cell cycle;cell division;chromosome;chromosome, telomeric region;DNA binding;double-stranded telomeric DNA binding;identical protein binding;mitosis;nucleus;regulation of transcription;telomere maintenance via telomerase	Hahn and Weinberg 2002,  Stability
7014	TERF2	telomeric repeat binding factor 2	NM_005652	NP_005643.1	ENSG00000132604	chr16:67948301 - 67977249	cell cycle;chromosome;chromosome, telomeric region;DNA binding;nucleus;protein binding;regulation of transcription;single-stranded telomeric DNA binding;telomere maintenance via telomerase	Hahn and Weinberg 2002
7015	TERT	telomerase reverse transcriptase	NM_198255, NM_198253	NP_937986.1, NP_937983.2	ENSG00000164362	chr5:1306842 - 1348104	chromosome;chromosome, telomeric region;DNA binding;nucleus;protein binding;RNA binding;RNA-dependent DNA replication;telomerase holoenzyme complex;telomere maintenance;telomeric DNA binding;telomeric template RNA reverse transcriptase activity;transferase activity	Hahn and Weinberg 2002,  Stability
7942	TFEB	transcription factor EB	NM_007162	NP_009093.1	ENSG00000112561	chr6:41760314 - 41766929	nucleus;positive regulation of transcription, DNA-dependent;regulation of transcription;transcription factor activity;transcription factor complex;transcription regulator activity	Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Translocation
7428	VHL	von Hippel-Lindau tumor suppressor	NM_198156, NM_000551	NP_937799.1, NP_000542.1	ENSG00000134086	chr3:10158531 - 10166649	anti-apoptosis;cell cycle;cell morphogenesis;cytosol;endoplasmic reticulum;mitochondrion;negative regulation of cell proliferation;negative regulation of progression through cell cycle;negative regulation of transcription from RNA polymerase II promoter;nucleus;positive regulation of cell differentiation;protein stabilization;protein ubiquitination;proteolysis;response to stress;transcription factor binding	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
